BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 8, 2008
View Archived Issues
Spin-Outs Offer Biotech Creative Financing Option
As of the end of August, biotech companies had raised $8.1 billion this year, less than half of the $19.3 billion raised in the same period last year, according to data from BioWorld Financial Watch. (BioWorld Financial Watch)
Read More
Money Raised Year to Date
Read More
Stock Winners and Losers For The Week
Read More
Public Financing of Biotechnology: August 2008
Read More
Other Financings of Public Biotechnology Companies: August 2008
Read More
Venture Capital and Other Investments in Private Biotechnology Companies: August 2008
Read More
Milestone Payments from Corporate Partners: August 2008
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More